Viewpoints

Avery Ince, VP, Medical Affairs - CVM Franchise, Janssen Shares his Views on New Data from P-III VOYAGER PAD Trial

Avery Ince, VP, Medical Affairs - CVM Franchise, Janssen Shares his Views on New Data from P-III VOYAGER PAD Trial

Shots: Avery spoke about the study design and the new data obtained from the P-III...

Anas Batikhi, Founder & CEO at Santechture Shares on RCM-Tech, A Necessity in The Healthcare Industry

Anas Batikhi, Founder & CEO at Santechture Shares on RCM-Tech, A Necessity in The Healthcare Industry

Shots: Anas spoke about revenue cycle management in the healthcare sector and the...

Eric Halioua, President & CEO at PDC*line Pharma Shares Insights on the Results from P-I/II Trial with PDC*lung01

Eric Halioua, President & CEO at PDC*line Pharma Shares Insights on the Results from P-I/II Trial with PDC*lung01

Shots: Eric shared the results from the first immunological results of its PDC-LUN...

Monica Mann, VP, of Medical Affairs for Global MS and Pipeline at Biogen Shares Insights on New Data on MS Therapies and Digital Health Research

Monica Mann, VP, of Medical Affairs for Global MS and Pipeline at Biogen Shares Insights on New Data on MS Therapies and Digital H...

Shots: Monica spoke about the new data from its multiple sclerosis therapies port...

Gregory Bell, CMO at Attralus Shares Insights from its License Agreement with Ossianix to Use Ossianix’s Brain Shuttle Technology

Gregory Bell, CMO at Attralus Shares Insights from its License Agreement with Ossianix to Use Ossianix’s Brain Shuttle Technology

Shots: Gregory initially spoke about the Attralus licensing agreement with Ossiani...

David Pendlebury, Head of Research Analysis, Institute for Scientific Information Shares Insights from its Annual Highly Cited Researchers List

David Pendlebury, Head of Research Analysis, Institute for Scientific Information Shares Insights from its Annual Highly Cited Res...

Shots: David first talked about Clarivate’s Highly Cited Researchers 2022 l...

Image